Variable | N | Percent (%) |
Age (ys) | 53.4 ± 11.7 | |
<60 | 441 | 79.3 |
≥60 | 115 | 20.7 |
Sex |
|
|
Male | 448 | 80.6 |
Female | 108 | 19.4 |
Hepatitis etiology |
|
|
HBV | 513 | 92.3 |
HCV | 2 | 0.3 |
No | 41 | 7.4 |
Serum AFP level (ng/ml) | 130.6 (0.7 - 339,567) | |
<20 ng/ml | 189 | 34.0 |
≥20 ng/ml | 367 | 66.0 |
Liver function |
|
|
Child-pugh A | 473 | 85.1 |
Child-pugh B | 68 | 12.2 |
Child-pugh C | 15 | 2.7 |
Site of recurrence |
|
|
Intrahepatic | 516 | 92.8 |
Extrahepatic | 17 | 3.1 |
Intrahepatic and extrahepatic | 23 | 4.1 |
Tumor size (cm) | 6.1 ± 10.5 | |
Tumor nodule |
|
|
Single | 298 | 51.7 |
Multiple | 258 | 44.8 |
Tumor thrombus |
|
|
Yes | 40 | 6.9 |
No | 516 | 89.6 |
Clinical stages |
|
|
Early stage | 298 | 53.6 |
Intermediate stage | 214 | 38.5 |
Advanced stage | 32 | 5.7 |
Terminal stage | 12 | 2.2 |
Disease-free interval (months) | 8 (2 - 195) |